Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Antonini

Showing results (1-10 of 494) with videos related to

Pageof 50
Sort By:
The Lancet. Neurology|December 11, 2019
New routes of dopaminergic drug delivery in patients with Parkinson's diseaseAngelo Antonini
Journal of Movement Disorders|May 29, 2014
Apomorphine and levodopa infusion therapies for advanced Parkinson's diseaseAngelo Antonini
The Lancet. Neurology|May 29, 2020
Health care for chronic neurological patients after COVID-19Angelo Antonini
Parkinsonism & Related Disorders|November 19, 2008
New strategies in motor parkinsonismAngelo Antonini
The Lancet. Neurology|January 12, 2010
Imaging for early differential diagnosis of parkinsonismAngelo Antonini
The Lancet. Neurology|December 17, 2011
Movement disorders: towards new therapies in Parkinson's diseaseAngelo Antonini
Movement Disorders Clinical Practice|October 27, 2018
The Face Behind the Mask: Can Imaging Help Early Parkinson Diagnosis?Angelo Antonini
The Lancet. Neurology|April 13, 2011
The conundrum of neuroprotection in Parkinson's diseaseAngelo Antonini
Neuropsychiatric Disease and Treatment|March 21, 2009
The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodiesAngelo Antonini
Parkinsonism & Related Disorders|August 19, 2007
Continuous dopaminergic stimulation--from theory to clinical practiceAngelo Antonini
Pageof 50

Showing results (1-10 of 494) with videos related to

Sort By:
Pageof 50
The Lancet. Neurology|December 11, 2019
New routes of dopaminergic drug delivery in patients with Parkinson's diseaseAngelo Antonini
Journal of Movement Disorders|May 29, 2014
Apomorphine and levodopa infusion therapies for advanced Parkinson's diseaseAngelo Antonini
The Lancet. Neurology|May 29, 2020
Health care for chronic neurological patients after COVID-19Angelo Antonini
Parkinsonism & Related Disorders|November 19, 2008
New strategies in motor parkinsonismAngelo Antonini
The Lancet. Neurology|January 12, 2010
Imaging for early differential diagnosis of parkinsonismAngelo Antonini
The Lancet. Neurology|December 17, 2011
Movement disorders: towards new therapies in Parkinson's diseaseAngelo Antonini
Movement Disorders Clinical Practice|October 27, 2018
The Face Behind the Mask: Can Imaging Help Early Parkinson Diagnosis?Angelo Antonini
The Lancet. Neurology|April 13, 2011
The conundrum of neuroprotection in Parkinson's diseaseAngelo Antonini
Neuropsychiatric Disease and Treatment|March 21, 2009
The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodiesAngelo Antonini
Parkinsonism & Related Disorders|August 19, 2007
Continuous dopaminergic stimulation--from theory to clinical practiceAngelo Antonini
Pageof 50